Real-time molecular vision
Truth in Every Layer: Real-Time AI for Surgery & Diagnostics
revolutionize surgical precision and diagnostic speed
REVEAL LIFE SCIENCE is a life-science technology platform that develops AI, molecular data infrastructure, and analytics to support regulated clinical products and future diagnostics.
We operate as a centralized R&D engine that pioneers breakthrough Raman spectroscopy technology, then transitions mature products into dedicated operating companies for focused commercialization.
With over a decade of research, clinical collaborations, and AI innovation, Reveal Life Science is transforming how medicine sees the unseen—bringing molecular precision to surgeons in the operating room and instant diagnostic insights to patients worldwide. Clinical products are developed and commercialized by affiliates, including Reveal Surgical.
Products Lines
Reveal surgical
Sentry™ Surgical Platform
Intraoperative decision-support technologies for tissue characterization
Sentry™ Precision
Investigational intraoperative tissue characterization system for neurosurgery
Intended to provide real-time molecular information to support surgical decision-making during brain tumor resection
PMA regulatory pathway
Sentry™ Scanner
Investigational ex vivo tissue assessment system for breast surgery
Intended to support intraoperative evaluation of excised tissue margins during lumpectomy procedures
NaviSense™
Investigational endoscopic tissue guidance system
Intended to support tissue targeting during minimally invasive endoscopic procedures
510(k) regulatory pathway anticipated
Clinical Context
In biopsy and surgical workflows, clinicians often lack immediate confirmation that collected tissue is adequate for diagnosis.
This can lead to:
repeat procedures
delays in diagnosis
increased patient burden
Approach
Clarion™ uses Raman spectroscopy and AI to analyze the molecular composition of tissue samples in near real time.
The system is designed to:
support assessment of tissue adequacy
improve confidence during sampling
integrate into existing clinical workflows
Development and Regulatory Status
Clarion is currently in advanced development and preparing for initial clinical deployment.
validated on extensive clinical datasets
undergoing system finalization and verification
preparing for submission under a Health Canada Class II regulatory pathway
Strategic Role
Clarion represents the initial clinical entry point for the Reveal platform.
It enables:
early clinical adoption
generation of real-world data
foundation for expansion into surgical and biofluid applications
Clarion is expected to represent the initial commercial pathway for the platform following regulatory clearance.
CLARION™ — PATHOLOGY APPLICATION
Advancing Toward Clinical Deployment
Clarion™ is the first clinical application of the Reveal platform, designed to assess tissue adequacy using molecular sensing at the point of sampling.
Early Access Program — Clarion™
Reveal is engaging a limited number of clinical partners to support the evaluation and refinement of Clarion™ ahead of regulatory submission.
Selected sites will participate in:
workflow integration and usability assessment
performance validation in real clinical settings
early access to platform capabilities
We are currently onboarding a small number of early access sites.
Platform Overview
Reveal Life Science develops a molecular sensing and AI platform designed to support regulated clinical applications and future diagnostic systems.
The platform is deployed through a staged strategy:
Pathology — initial clinical entry point through tissue assessment
Surgery — intraoperative molecular characterization
Biofluids — longitudinal biological monitoring programs
Rather than operating solely as an R&D engine, Reveal is advancing a structured transition from validation to clinical deployment and scalable applications.
Reveal BIOFLUIDS
Reveal Biofluids: Rapid Diagnostic Revolution
Reveal Biofluids is transforming diagnostics by enabling real‑time detection of disease markers in saliva, urine, and blood — without the need for invasive procedures or lengthy lab analysis. Our platform brings laboratory‑grade accuracy directly to the point of care.
From early cancer detection to metabolic monitoring and infectious disease screening, our biofluid technology delivers fast, affordable, and scalable solutions. By combining spectroscopy with machine learning (ML), we empower clinicians, pharmacies, and even remote healthcare providers to make faster, data-driven decisions that save lives.
Reveal INSIGHt ATLAS
Reveal InsighT — The Unified Platform for Molecular Intelligence
Reveal Insight Atlas operate as a single molecular intelligence ecosystem — combining the world’s first spectral data warehouse with a secure, cloud-based AI engine.
By organizing and analyzing millions of spectral signatures from tissues and biofluids, the platform transforms raw molecular data into clear, real-time insights.
This continuous learning system empowers clinicians, researchers, and health networks with precision diagnostics, treatment decision support, and population-scale analytics — bridging the gap between molecular discovery and clinical action.
Unleashing the Power of Real‑Time Molecular Insights
-
Faster Than Ever
Detect critical changes in real time, from cancer cells to environmental anomalies, with results in seconds.
-
A Unique Data Source
Reveal A.I builds an unprecedented molecular database − rich in biomarkers, spectra, and physico‑chemical patterns − that drives smarter therapeutic decisions and innovations.
-
Cost‑Effective Precision
Diagnostics that aim to improve speed and accessibility, supporting broader access to high-impact testing.
-
Non‑Invasive & Multi‑Purpose
Analyze biofluids, environmental samples, and industrial liquids without invasive procedures or sample preparation.
-
Proactive Health Monitoring
Potential to support faster clinical monitoring across a range of health conditions.
-
Remote-Ready Technology
Deployable in remote or extreme environments, ensuring vital data collection and diagnostics anywhere.
-
AI-Powered Evolution
Our proprietary SaaS platform continuously integrates new capabilities and biomarkers via simple software updates, adapting to emerging needs.
-
Validated by Global Experts
Backed by over 9 years of research and 180+ peer-reviewed publications, trusted by hospitals, universities, and government institutions across three continents.
-
Multi-Domain Impact
From precision surgery to pandemic prevention, Reveal Explorer and Reveal SENTRY™ support smarter decisions in healthcare, animal health, food safety, and industrial monitoring.
